Drug
Vv261
Vv261: highest development phase Phase 1, developed by Vigonvita Life Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vigonvita Life Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| VV261 NCT07927218 | Phase 1 | Severe Fever With Thrombocytopenia Syndrome |
Latest
No recent events.
Follow Vv261 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.